![Winfried Albert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Winfried Albert
Directeur des opérations chez Alere Diagnostics GmbH
Profil
Winfried Albert is currently the Chief Operating Officer at Alere Diagnostics GmbH since 2013.
He previously worked as a Senior Director at Roche Diagnostics GmbH.
Postes actifs de Winfried Albert
Sociétés | Poste | Début |
---|---|---|
Alere Diagnostics GmbH
![]() Alere Diagnostics GmbH Medical SpecialtiesHealth Technology Alere Diagnostics GmbH develops diagnostics to detect circulating tumor cells in tumor patients. The company's tumor diagnostics are kits consisting of reagents for immunomagnetic selection, mRNA isolation and multiplex RT-PCR and can be performed on standard technology platforms. The products have analytical sensitivity (2 cells in 5 ml blood) and specificity (greater 90%) achieved through the combination of multi-marker tumor cell enrichment and multiplex gene expression profiling for treatment of cancer. The company was founded in 1999 and is headquartered in Langenhagen, Germany. | Directeur des opérations | 21/05/2013 |
Anciens postes connus de Winfried Albert
Sociétés | Poste | Fin |
---|---|---|
Roche Diagnostics GmbH
![]() Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Alere Diagnostics GmbH
![]() Alere Diagnostics GmbH Medical SpecialtiesHealth Technology Alere Diagnostics GmbH develops diagnostics to detect circulating tumor cells in tumor patients. The company's tumor diagnostics are kits consisting of reagents for immunomagnetic selection, mRNA isolation and multiplex RT-PCR and can be performed on standard technology platforms. The products have analytical sensitivity (2 cells in 5 ml blood) and specificity (greater 90%) achieved through the combination of multi-marker tumor cell enrichment and multiplex gene expression profiling for treatment of cancer. The company was founded in 1999 and is headquartered in Langenhagen, Germany. | Health Technology |
Roche Diagnostics GmbH
![]() Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |